GlaxoSmithKline: all 4,196 studies
Page 31 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- Study on the Prevalence of Human Papillomavirus Types in Women >= 15 Years of Age in the Kingdom of Saudi ArabiaCompletedNCT01213459
- A Study to Assess the Relative Bioavailability of Tablet Formulations of GSK2248761 in Healthy Adult Subjects. SGN114435CompletedNCT01209117Phase 1
- Pharmacokinetics and Safety of GSK1325756 in Elderly Subjects and Adult Subjects of in the Fed and Fasted States and in the Presence of a Proton Pump InhibitorsCompletedNCT01209104Phase 1
- Utility and Work Productivity Data for Economic Evaluation of Breast Cancer Therapies in the Netherlands and SwedenCompletedNCT01209091
- GSK1349572 Drug Interaction Study With Fosamprenavir/RitonavirCompletedNCT01209065Phase 1
- First Time in Human Study With GSK1325756CompletedNCT01209052Phase 1
- A Repeat Dose Positron Emission Tomography Study With GSK1144814CompletedNCT01209039Phase 1
- Corrected QT (QTc) Study With Flucticasone Furoate and GW642444CompletedNCT01209026Phase 1
- Type Distribution of Human Papillomavirus in Adult African Women Diagnosed With Invasive Cervical CancerCompletedNCT01207999
- An Observational Study on the Prevalence of Human Papillomavirus Types in Women in the Kingdom of BahrainCompletedNCT01205412
- ZIAGEN® Post-marketing SurveillanceCompletedNCT01205243
- Lapatinib or Trastuzumab Given Prior to Surgery With Chemotherapy in Patients With Early Breast CancerWithdrawnNCT01205217Phase 2
- G6PD (Glucose-6-phosphate Dehydrogenase) Study to Evaluate Hemolysis Potential of TFQ (Tafenoquine)CompletedNCT01205178Phase 1
- Study to Identify and Characterize the Bacteria Causing Acute Otitis Media Episodes in Young Children in Saudi ArabiaCompletedNCT01204385
- A Retrospective Survey of the Burden of Rotavirus Gastroenteritis (RV GE) and Nosocomial RV GE in JapanCompletedNCT01202201
- Study to Estimate the Disease Burden of Acute Rotavirus Gastroenteritis in Children < 5 Years in United Arab EmiratesCompletedNCT01201252
- A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome MeasuresCompletedNCT01199757
- A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.TerminatedNCT01195974Phase 1
- A 35 Day Study to Investigate the Effects of GSK1521498 on Bodyweight in Obese Subjects With Over-Eating Behaviours.CompletedNCT01195792Phase 2
- Malignancy Meta Analysis for BRL49653CompletedNCT01195259
- Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-PaclitaxelCompletedNCT01192165Phase 1
- A Study of PNT2258 in Patients With Advanced Solid TumorsCompletedNCT01191775Phase 1
- Drug Use Investigation for Cervarix®CompletedNCT01187927
- Alcohol Interaction StudyCompletedNCT01181908Phase 1
- Study to Assess the Incidence of Intussusception in Children < 2 Years of Age in SingaporeCompletedNCT01177839
- Effectiveness Study of GSK Biologicals' Rotarix TM Vaccine in Hospitalized ChildrenCompletedNCT01177826
- Study to Evaluate the Effectiveness of Rotarix™ Against Severe Gastroenteritis Among Hospitalized Children in BrazilCompletedNCT01177657
- Trends Over Time (1990-2010) of Diarrhoea-related Hospitalizations and Deaths in Children < 5 Years of Age in BrazilCompletedNCT01175252
- Effectiveness of Flu Vaccination and Burden of Illness Among Community-dwelling Elderly With Influenza Like Illness in BrazilTerminatedNCT01171157
- Trends Over Time (1990-2010) of Diarrhoea-related Incidence, Hospitalizations and Deaths in Children of PanamaCompletedNCT01171144
- Bupropion and Specific Cardiovascular MalformationsCompletedNCT01165255
- A Drug Interaction Study With Fluticasone Furoate/GW642444 Inhalation Powder and KetoconazoleCompletedNCT01165125Phase 1
- Study to Evaluate the Reactogenicity and Safety of Rotarix™ in Chinese AdultsCompletedNCT01162590Phase 1
- Oral GW766944 (Oral CCR3 Antagonist)CompletedNCT01160224Phase 2
- Meta-analysis of Efficacy of TopotecanCompletedNCT01160185
- A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy AdultsCompletedNCT01160172Phase 1
- Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella PertussisCompletedNCT01160081
- Study to Characterize and Identify Bacteria Causing Acute Otitis Media in Young Egyptian ChildrenWithdrawnNCT01160055
- A Blinded, Dose Ascending Study to Assess the Pharmacokinetics, Safety and Tollerability of Repeat Inhaled Doses of Nebulised GW870086X in Healthy Adult Male Volunteers.CompletedNCT01160003Phase 1
- Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by SurgeryTerminatedNCT01159964Phase 1
- Analysis of Trends Over Time of Hepatitis Related Incidence in PanamaCompletedNCT01159951
- Surveillance Study to Determine the Trends in Acute Hepatitis A Among Panamanian ChildrenCompletedNCT01159925
- An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus Types in Women in EgyptCompletedNCT01158209
- Insulin Resistance as Primary Pathogenesis in Newly Diagnosed, Drug naïve Type 2 Diabetes Patients in KoreaCompletedNCT01154244
- Study to Evaluate Darapladib in Moderately Hepatically Impaired SubjectsCompletedNCT01154114Phase 1
- A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular DegenerationCompletedNCT01154062Phase 1
- Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular DystrophyCompletedNCT01153932Phase 2
- Post-marketing Safety Study of Autoimmune Diseases Following Cervarix® VaccinationCompletedNCT01153906
- United States Pharmacovigilence Retapamulin-PrescribingCompletedNCT01153880
- EU PV for Retapamulin-PrescribingCompletedNCT01153828
- An Open Label Positron Emission Tomography Study in Healthy Male Subjects to Investigate Brain DAT and SERT Occupancy,Pharmacokinetics and Safety of Single Oral Doses of GSK1360707, Using 11C- PE2I and 11C-DASB as PET LigandsCompletedNCT01153802Phase 1
- A Phase 1 Study to Evaluate the Effect of GSK256073, an HM74A Receptor Agonist, on Glucose and NEFA Levels in Type 2 DiabeticsCompletedNCT01147861Phase 1
- A Drug Interaction Study With Albiglutide and WarfarinCompletedNCT01147731Phase 1
- A Drug Interaction Study of Albiglutide and DigoxinCompletedNCT01147718Phase 1
- A Drug Interaction Study of Simvastatin and AlbiglutideCompletedNCT01147692Phase 1
- Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy SubjectsTerminatedNCT01140412Phase 1
- Safety, Pharmacokinetics (PK) of AKT and MEK CombinationCompletedNCT01138085Phase 1
- A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.CompletedNCT01138072Phase 1
- Study of a Focal Adhesion Kinase Inhibitor in Subjects With Solid TumorsCompletedNCT01138033Phase 1
- A Phase II, Randomized, Open-label Study of Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive and p95HER2-positive Metastatic Breast CancerWithdrawnNCT01137994Phase 2
- W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With AcneCompletedNCT01132443Phase 1
- A Double-blind, Escalating Dose, Randomized, Placebo-controlled Study Assessing PK, Safety, Tolerability in Non-ambulant DMD SubjectsCompletedNCT01128855Phase 1
- Lamivudine(LAM) Good Responder StudyCompletedNCT01128686
- Pharmacokinetic and Safety of GSK573719 and GW642444 Administered Individually and Concurrently, With Verapamilin in Healthy SubjectsCompletedNCT01128634Phase 1
- A Study to Evaluate the Potential of Tazarotene Foam to Cause an Allergic Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers.CompletedNCT01119651Phase 1
- A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy VolunteersCompletedNCT01115322Phase 1
- A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy VolunteersCompletedNCT01114841Phase 1
- A Study to Assess the Relative Bioavailability of Four New Formulations of GSK1605786 in Healthy SubjectsCompletedNCT01114607Phase 1
- A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy VolunteersCompletedNCT01112787Phase 1
- A Study of MK-4827 in Combination With Standard Chemotherapy in Participants With Advanced Solid Tumors (MK-4827-008 AM1)TerminatedNCT01110603Phase 1
- Efficacy Study in Lumbosacral RadiculopathyCompletedNCT01110057Phase 2
- Study of a Birth Dose of GlaxoSmithKline Biologicals' 251154 VaccineWithdrawnNCT01110044Phase 2
- Ofatumumab Cardiac Repolarization (QTc) Study in Fludarabine-Refractory Chronic Lymphocytic Leukemia SubjectsCompletedNCT01110031Phase 1
- GSK573719 IV Enabling StudyCompletedNCT01110018Phase 1
- Study to Assess the Safety of GSK Biologicals' Liquid Human Rotavirus Vaccine in Healthy InfantsCompletedNCT01107587Phase 1
- An Evaluation of Two Novel Nasal Strip Prototypes on Nasal PatencyCompletedNCT01105949Phase 1
- A Drug Interaction Study Evaluating GSK2248761 and Raltegravir Pharmacokinetics in Healthy Adult SubjectsCompletedNCT01101893Phase 1
- A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy SubjectsCompletedNCT01101568Phase 1
- Repeat Dose Subcutaneous Rhumatoid Arthritis Efficacy StudyCompletedNCT01101555Phase 1
- A Study in Healthy Adults Having Received a Single Vaccine Administration to Support the Development of Immunological AssaysCompletedNCT01099488Not applicable
- GSK1349572 Drug Interaction Study With EfavirenzCompletedNCT01098526Phase 1
- GSK1349572 Relative Bioavailability StudyCompletedNCT01098513Phase 1
- Long-term Follow-up of Participants From Studies Evaluating GSK HIV VaccineCompletedNCT01092611Phase 1
- Pharmacokinetics, Effect of Food, Safety and Tolerability of a New Tablet Formulation of GSK1144814 in Healthy SubjectsCompletedNCT01090440Phase 1
- Intravenous Microdose Pharmacokinetic (PK) Study With [14C]-GSK2239633CompletedNCT01086462Phase 1
- Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese AdultsCompletedNCT01086449Phase 1
- Study to Evaluate the Safety of Rotarix™ in Chinese ChildrenCompletedNCT01086436Phase 1
- To Investigate the Clinical Efficacy of an Experimental ToothpasteWithdrawnNCT01079910Phase 1
- Regulatory Nebilet PMSCompletedNCT01077661
- Brain Metastasis in Breast Cancer PatientsCompletedNCT01077648
- PENTA Fosamprenavir StudyCompletedNCT01077635
- Flixonase Safety in Patients With Allergic Rhinitis (AR)CompletedNCT01077609
- Fractures Stratified by HIV and Antiretroviral Therapy (ART) StatusCompletedNCT01077557
- Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid ArthritisTerminatedNCT01077531Phase 1
- An Evaluation of the Pharmacokinetics of an Oral Contraceptive (Brevicon) When Co-administered With Albiglutide .CompletedNCT01077505Phase 1
- Study to Identify and Characterize the Bacteria Causing Acute Otitis Media Episodes in Young Children in TaiwanTerminatedNCT01072227
- A Safety Study to Evaluate Pazopanib Eye Drops in Healthy VolunteersCompletedNCT01072214Phase 1
- Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation and Food EffectCompletedNCT01072162Phase 1
- Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy VolunteersCompletedNCT01068925Phase 1
- Breast Cancer With Over-expression of erbB2-BRAINSTORMCompletedNCT01064349